Clinical Trial Update: Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating topiramate for Prader-Willi syndrome was terminated; no efficacy results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• Topamax (Topiramate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Prader-Willi Syndrome | Phase 3 | Status: TERMINATED